Centessa Pharmaceuticals PLC ADR Earnings

The next earnings date for Centessa Pharmaceuticals PLC ADR is August 18, 2025.

They are scheduled to announce earnings after the market closes that day.

Analyst Estimates of Centessa Pharmaceuticals PLC ADR Earnings

Report DateEstimated Earnings Per Share
11/17/2025$-0.34
08/18/2025$-0.33

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Centessa Pharmaceuticals PLC ADR Earnings: Historical

Report DateBefore/After MarketEarnings Per ShareSurprise %
11/12/2024---$-0.374.52%
08/13/2024---$-0.40-0.83%
05/13/2024After Market$-0.389.52%
03/28/2024After Market$-0.3820.83%
11/13/2023After Market$-0.4023.08%
08/14/2023Before Market$-0.2646.94%
05/12/2023Before Market$-0.53-29.27%
03/30/2023Before Market$-0.456.25%
11/10/2022Before Market$-0.57-1.79%
08/10/2022Before Market$-0.69-21.05%
05/16/2022Before Market$-0.6014.29%
03/30/2022After Market$-0.68-13.33%
11/15/2021Before Market$-0.4518.18%
08/16/2021Before Market$-0.651.52%
06/01/2021After Market$-0.1262.50%
03/31/2021---$-4.97---

More About Centessa Pharmaceuticals PLC ADR

Website
https://centessa.com
Country
USA
Full Time Employees
86

Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines. Its lead clinical-stage program includes ORX750, an orally administered OX2R agonist in a Phase 2a study for the treatment of idiopathic hypersomnia and narcolepsy type 1 and 2. The company also develops ORX142 for the treatment of neurological and neurodegenerative disorders, as well as other potential symptoms, including excessive daytime sleepiness, impaired attention, cognitive deficits, and fatigue; and ORX489 for the treatment of neuropsychiatric disorders. In addition, it offers LockBody, which is designed to selectively drive potent effector function activity, such as CD3, into the tumor microenvironment. Centessa Pharmaceuticals plc was incorporated in 2020 and is headquartered in Altrincham, the United Kingdom.

“Centessa Pharmaceuticals PLC ADR Earnings” Can Refer to the Centessa Pharmaceuticals PLC ADR Earnings Date

Some people say “Centessa Pharmaceuticals PLC ADR earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Centessa Pharmaceuticals PLC ADR position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Centessa Pharmaceuticals PLC ADR Stock on the Earnings Date

If you own Centessa Pharmaceuticals PLC ADR stock (CNTA) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Centessa Pharmaceuticals PLC ADR might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Centessa Pharmaceuticals PLC ADR shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Centessa Pharmaceuticals PLC ADR Earnings

You can contact us any time if you would like to ask questions about Centessa Pharmaceuticals PLC ADR earnings or anything else related to the stock market.